Erratum to “Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities”

Erratum to “Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities”

Saved in:

Bibliographic Details
Main Authors:	Daniel Arthur B. Kasal, Ernesto L. Schiffrin
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	International Journal of Hypertension
Online Access:	http://dx.doi.org/10.1155/2012/132598
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Renin-Angiotensin-Aldosterone System as a Therapeutic Target in Late Injury Caused by Ischemia-Reperfusion
by: Simón Quetzalcóatl Rodríguez-Lara, et al.
Published: (2018-01-01)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
by: Jing Ye, et al.
Published: (2018-01-01)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
by: P. Stiefel, et al.
Published: (2011-01-01)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
by: Maricica Pacurari, et al.
Published: (2014-01-01)

Renin-angiotensin-aldosterone system in ISIAH rats with stressinduced arterial hypertension
by: A. D. Dubinina, et al.
Published: (2017-02-01)

Immune Optimization as a Preventive and Therapeutic Adjunct for the Management of Renin–Angiotensin–Aldosterone System Dysfunction Diseases: A Review
by: Michael T. Okafor, et al.
Published: (2024-07-01)

Angiotensin II and Renal Tubular Ion Transport
by: Patricia Valles, et al.
Published: (2005-01-01)

Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
by: Michelle A. Clark, et al.
Published: (2013-01-01)

Angiotensin-(1-7) and Alamandine Promote Anti-inflammatory Response in Macrophages In Vitro and In Vivo
by: Melissa de Carvalho Santuchi, et al.
Published: (2019-01-01)

The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy
by: Qi Feng, et al.
Published: (2020-01-01)

Dose‐exposure‐response of CARDALIS® (benazepril/spironolactone) on the classical and alternative arms of the renin‐angiotensin‐aldosterone system in healthy dogs
by: Elizabeth Manson, et al.
Published: (2025-01-01)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
by: Jing Ye, et al.
Published: (2017-01-01)

Publisher Erratum: Matter-geometry interplay in new scalar tensor theories of gravity
by: Mihai Marciu
Published: (2024-12-01)

Renin–angiotensin–aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study
by: Katharina Krenn, et al.
Published: (2025-01-01)

Clinical Characteristics of Aldosterone- and Cortisol-Coproducing Adrenal Adenoma in Primary Aldosteronism
by: Lu Tang, et al.
Published: (2018-01-01)

Aldosteronism and Resistant Hypertension
by: Maria Czarina Acelajado, et al.
Published: (2011-01-01)

Roles of Brain Angiotensin II in Cognitive Function and Dementia
by: Masaki Mogi, et al.
Published: (2012-01-01)

Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study
by: Molly Moore Jeffery, et al.
Published: (2022-07-01)

The Angiotensin II Type 2 Receptor in Brain Functions: An Update
by: Marie-Odile Guimond, et al.
Published: (2012-01-01)

Interleukin-2/Anti-Interleukin-2 Immune Complex Expands Regulatory T Cells and Reduces Angiotensin II-Induced Aortic Stiffening
by: Beenish Majeed, et al.
Published: (2014-01-01)

New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis
by: Anderson J. Ferreira, et al.
Published: (2012-01-01)

Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System
by: Farzaneh Ketabchi, et al.
Published: (2022-01-01)

Angiogenesis and Its Therapeutic Opportunities
by: So Young Yoo, et al.
Published: (2013-01-01)

Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation
by: Eriko Nakano, et al.
Published: (2024-05-01)

Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors
by: Hajaralsadat Hosseini-Dastgerdi, et al.
Published: (2022-01-01)

The Interplay of Aging and PANoptosis in Osteoarthritis Pathogenesis: Implications for Novel Therapeutic Strategies
by: Liu S, et al.
Published: (2025-02-01)

The Immunohistochemistry Profile of Lymphocytic Gastritis in Celiac Disease and Helicobacter Pylori Infection: Interplay between Infection and Inflammation
by: Efrat Broide, et al.
Published: (2007-01-01)

Twenty-Four-Hour Urinary Aldosterone Predicts Inappropriate Left Ventricular Mass Index in Patients with Primary Aldosteronism
by: Chi-Sheng Hung, et al.
Published: (2013-01-01)

Therapeutic Options in the Treatment and Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Ulceration
by: Malcolm C Champion
Published: (1990-01-01)

Erratum to “IgG4 Inflammatory Pseudotumor of the Kidney”
by: Ahmad Alkhasawneh, et al.
Published: (2013-01-01)

High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response
by: Tianzhu Tao, et al.
Published: (2021-01-01)

Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
by: Akihiro Sunaga, et al.
Published: (2022-06-01)

Bone and Mineral Metabolism in Patients with Primary Aldosteronism
by: Luigi Petramala, et al.
Published: (2014-01-01)

Suppression of Aldosterone Synthesis and Secretion by Channel Antagonists
by: Keiichi Ikeda, et al.
Published: (2012-01-01)

Pathology and gene mutations of aldosterone-producing lesions
by: Koshiro Nishimoto, et al.
Published: (2023-12-01)

Prismatic Dieudonné Theory – ERRATUM
by: Johannes Anschütz, et al.
Published: (2025-01-01)

T Lymphocyte Autoreactivity in Inflammatory Mechanisms Regulating Atherosclerosis
by: Elisabetta Profumo, et al.
Published: (2012-01-01)

Therapeutic Applicability of Anti-Inflammatory and Proresolving Polyunsaturated Fatty Acid-Derived Lipid Mediators
by: Gerard L. Bannenberg
Published: (2010-01-01)

The Effect of Endogenous Angiotensin II on Alveolar Fluid Clearance in Rats with Acute Lung Injury
by: Jia Deng, et al.
Published: (2012-01-01)

Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
by: Xuran Wang, et al.
Published: (2025-01-01)